2 high-quality dividend-hikers I’d buy and hold for the long term

Sometimes it’s just best to pay a little more for a slice of a great company. Paul Summers picks out two favourites.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Many investors love the thrill of buying unloved or secret stocks in the hope that their true value is realised by others later down the line. 

That said, there’s also something about paying more (but not too much) for quality companies that don’t require constant monitoring and just letting them get on with things. 

I’d put Vimto-maker Nichols (LSE: NICL) firmly in the latter category, alongside industry peers AG Barr and Britvic. Don’t get me started on Fevertree

Reassuringly expensive

Today’s results for 2018 from the mid-cap were further evidence of just how reliable the company is. Revenue was up 7% to £142m and pre-tax profit, before exceptional items, rose 4% to £31.8m.

Commenting on results, non-executive chairman John Nichols said the company’s performance in the UK — where total sales increased 12.7% to £114.6m  had been “driven by the strength of the Vimto brand” which was “continuing to outperform the wider soft drinks market.” Helping to justify recent investment in this part of the company, sales from Nichol’s Out of Home channel also increased by 15.2%.

Performance overseas was more mixed with progress in Africa offset by weaker sales in the Middle East, as a result of the ongoing conflict in Yemen and issues over shipments to Saudi Arabia. All told, international sales were almost 12% lower (£27.4m) than in 2017. A temporary blip, I think.

Looking ahead, there’s little to make me think that Nichols will encounter any serious difficulties in the rest of 2019 (although the aforementioned conflict will need to be monitored). It’s debt free, has loads of cash, a portfolio of excellent brands, generates high margins and returns on capital and, considering our forthcoming exit from the EU, isn’t completely reliant on the UK market for its success. 

Aside from the above, there’s also the fact that Nichols consistently hikes its cash returns to shareholders. Today’s 14.5% increase to the final dividend (26.8p) brings the total for the last financial year to 38.1p — up 13.7% and representing a trailing yield of 2.4% based on the share price at the time of writing. That may look average but, as mentioned here, regular hikes to small dividends are often better than large but stagnant returns. 

Changing hands for 21 times forecast 2019 earnings before this morning, Nichols is one of those companies that very rarely goes on sale. Those who already hold should continue doing so, in my opinion.

Dividend hiker

Another share that could be worth paying up for is gas mask supplier and milking point solutions provider Avon Rubber (LSE: AVON).

The small-cap’s shares possess many of the attributes boasted by Nichols, including a bulletproof balance sheet (no debt and £46.5m in cash at the end of the last financial year), high returns on capital, and regular double-digit hikes to the annual dividend.

The firm recently reported that its Protection arm had “enjoyed a solid start to the year” after securing a new contract from the US Department of Defense. The first order relating to this — 7,000 mask systems worth $17.8m — has now arrived. As a result (and despite “tougher dairy market conditions” impacting on its milkrite/InterPuls business), Avon’s management remains confident of achieving its expectations for the full year.

At almost 17 times forecast earnings, this stock isn’t screamingly cheap, but is still very reasonable considering the company’s solid track record.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended Nichols. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »